Immune Thrombocytopenic Purpura

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2015-07-30
Clinical Trial Update: MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP [Phase 2, Phase 3]
The MONICA-SC trial evaluating Blisibimod (A-623) for Immune Thrombocytopenic Purpura/Idiopathic Thrombocytopenic Purpura has been withdrawn…